FIELD: medicine.
SUBSTANCE: group of inventions relates to medicine, namely to a method of treatment or prevention of epilepsy. For this purpose recombinant human interleukin-2 is introduced to the patient with a reduced BDNF concentration in blood serum and/or plasma. The group of inventions also relates to the application of interleukin-2 for the treatment or prevention of the said disease.
EFFECT: application of the claimed group of inventions makes it possible to apply recombinant interleukin-2 as a single therapeutic agent in the treatment of pharmacoresistant epilepsy, associated with the insufficient BDNF production.
8 cl, 5 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING EPILEPSY | 2013 |
|
RU2538724C1 |
| METHOD FOR EVALUATING EPILEPSY PHARMACOTHERAPY EFFECTIVENESS | 2000 |
|
RU2164688C1 |
| EXPRESS-ESTIMATION METHOD FOR EVALUATING EPILEPSY TREATMENT EFFECTIVENESS WITH DEPAKIN INJECTIONS UNDER EEG-CONTROL | 2004 |
|
RU2314803C2 |
| METHOD FOR TREATMENT OF EPILEPTIC PATIENTS | 2005 |
|
RU2314097C2 |
| METHOD OF TREATING INFLUENZA AND INFLUENZA-LIKE ILLNESSES COMPLICATED WITH PNEUMONIA | 2012 |
|
RU2518277C2 |
| METHOD FOR LIFESPAN EVALUATION IN PATIENTS WITH LOCALLY ADVANCED AND DISSEMINATED RENAL CELL CARCINOMA | 2009 |
|
RU2405150C1 |
| METHOD FOR IMMUNE CORRECTION IN PNEUMONIA | 2006 |
|
RU2305555C1 |
| AUTOLOGOUS VACCINE FOR ONCOTHERAPY AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2392946C2 |
| METHOD OF DETERMINING TACTICS OF TREATING LOCALLY ADVANCED AND DISSEMINATED RENAL CELL CARCINOMA | 2009 |
|
RU2403056C1 |
| PREVENTIVE METHOD OF SUPPURATIVE-SEPTIC COMPLICATIONS CASUED BY SEVERE COMBINED INJURY | 2006 |
|
RU2326687C1 |
